...P. Powell; D. Neal; I. Gibb; L. Wilson; R. Hall Serum prostatic acid phosphatase and prostate-specific antigen have been measured in a group of 106 cases of newly diagnosed prostate cancer. The serum levels of the tumour markers have been correlated with the clinical and ultrasound staging...

... prostatic hyperplasia. Moreover, we determined prostatic acid phosphatase (PAP) by enzyme immunoanalysis, resulting in 9/78 false-positives and 18/78 false-negatives. Also, we carried out a morphometric analysis of the cytologic samples which showed good correlation with the cytologic diagnosis except...

...C. Curatolo; G.M. Ludovico; M. Correale; A. Pagliarulo; I. Abbate; E. Cirrillo Marucco; A. Barletta We report our experience in the follow-up of 63 patients with advanced prostate adenocarcinoma. We used prostate-specific antigen and prostatic acid phosphatase in 27 patients; in 36 patients we...

...S. Omacini; R. Mione; M. Barichello; U. Santucci Delli Ponti; A. Bolgan; G.P. Contemori; S. Petracco; G.C. Capitanio; P.M. Donisi; M. Gion Serum levels of prostatic acid phosphatase (PAP) and prostate-specific antigen (PSA) were measured in 78 patients with benign prostate hyperplasia and compared...

...Ü. Şimşek; S. Kutlu; İ. Yavaşçaouğlu; B. Oktay; M. Özyurt The seasonal pattern of prostatic acid phosphatase (PAP) and prostate specific antigen (PSA) in nonmalignant males was investigated. Serum levels were measured in 1,540 men during a 3-year period with radioimmunoassay methods using...

...I. Romics; L. Galamb The authors measured serum prostate-specific antigen (PSA) and prostatic acid phosphatase concentration in histologically positive prostate hyperplastic and carcinomatous patients before, and 30-60 min and 24 h after prostate manipulation (rectal digital examination, cystoscopy...

...J. W. Hetherington; J.K. Siddall; E.H. Cooper Changes in the serial measurements of serum prostatic acid phosphatase (PAP), and prostatic specific antigen (PSA) have been compared against changes in serial bone scans in 120 patients with prostatic cancer. Of 54 patients who presented with negative...

... 10 µg/l) as established in 74 prostate carcinoma patients was 31 % for category To (n = 13), 56 % for category Ti_2 (n = 16), 75 % for category T(3_4) (n = 20)and 100% for category M(1) or Ni(1-4) (n = 25). In an earlier study prostatic acid phosphatase (PAP) was measured in these same samples. PSA...

...J.K. Siddall; E.H. Cooper; D.W.W. Newling; M.R.G. Robinson; P. Whelan Serum prostatic specific antigen (PSA) and prostatic acid phosphatase (PAP) were evaluated with double monoclonal radioimmunoassays. In 250 patients with prostatic cancer the normal limits were as follows: PSA 0.1-2.7 ng/ml...

...M.P. Wirth; J. Gomes de Oliveira; H.G.W. Frohmüller Determination of serum prostatic acid phosphatase by a monoclonal antibody-based radioimmunoassay(RIA) was compared to a polyclonal antibody-based enzyme immunoassay (EIA) to study the clinical value of both test systems. The 97.5 percentile of 48...

...F. Algaba; G. Chéchile; E. Zungri A correlation between the serum levels of testosterone and the tissular intensity of prostatic acid phosphatase(PAP) and prostate-specific antigen (PSA) in normal prostates has been demonstrated. In prostatic cancer patients, we studied the correlation between...

...J. Morote Robles; A. Ruibal Morell; J. Palou Redorta; J.A. de Torres Mateos; A. Soler Roselló We assayed prostatic specific antigen and prostatic acid phosphatase serum levels in 1,383 patients using a double antibody radioimmunoassay (RIA) 125I. Establishing the upper normal limit in 10 ng/ml...

...E.H. Cooper; N.B. Pidcock; D. Daponte; R.W. Glashan; E. Rowe; M.R.G. Robinson A longitudinal study of serum prostatic acid phosphatase (sPAP) in 167 cases of carcinoma of the prostate was made using an enzyme-linked immunosorbent assay. The sensitivity of the assay was valuable in accurately...

... of prostate-specific antigen(PSA) and prostatic acid phosphatase (PAP), a specimen from the prostate involving the cystic wall was collected. Hematoxylin-eosin staining and immunohistochemical staining for PSA were performed. Results: All aspirated fluid specimens were yellowish and clear without any sperm...

...M.P. Wirth; H.G.W. Frohmüller Serum values of prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP) were determined in 180 patients prior to pelvic lymphadenectomy and radical prostatectomy and in 40 patients prior to pelvic lymphadenectomy alone. In all tumor stages, PSA...

... prostate cancer. Prostate-specific antigen (PSA), prostatic acid phosphatase (PAP), and radionuclide bone scan were considered. The tumor marker positivity was assessed according to dynamic criteria (>50% increase between consecutive samples). 108 patients entered the study; 72 patients treated...

...Susumu Akimoto; Motoyuki Masai; Motoyuki Akakura; Jun Shimazaki Abstract To estimate the growth rate of prostate cancer, the doubling times of prostatespecific antigen (PSA) and prostatic acid phosphatase (PAP) were determined in 51 patients: 44 were refractory to endocrine therapy, and 7 were...

...A. Lewenhaupt; P. Ekman; P. Eneroth; A. Kallner Serum concentrations of prostatic acid phosphatase, prostate-specific antigen, neopterin, osteocalcin,tissue polypeptide antigen, and CA-50 were measured before onset of treatment in 86 patients suffering from prostatic carcinoma. In an attempt...

...Haakon Waehre; Eva Hoff Wanderaas; Elisabeth Paus; Sophie D. Fossa Prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP) were determined in the serum of 69 patients with clinical T3/T4 M0 prostatic cancer before staging lymphadenectomy. In principle, high-dose radiotherapy was given...

... in the eighties, at our institution PC patients were monitored by PSA, prostatic acid phosphatase (PAP), alkaline phosphatase (AP), digital-rectal examination, renal and bladder ultrasound every 3 months, abdominopelvic computerized tomography (CT) and bone scan every 6 months. Between 1988 and 1994, 80 patients...